Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine (GNMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aevi Genomic Medicine 435 DEVON PARK DRIVE SUITE 715 WAYNE PA 19087 USA

www.aevigenomics.com P: 610-254-4201

Description:

Aevi Genomic Medicine Inc. is focused on genomic medicine. The Company focuses on translating genetic discoveries into novel therapies. Its product candidates include AEVI-001 and AEVI-002 which are in clinical trial stage. Aevi Genomic Medicine Inc., formerly known as Medgenics Inc., is based in WAYNE, United States.

Key Statistics

Overview:

Market Capitalization, $K 12,893
Shares Outstanding, K 77,714
Annual Sales, $ 0 K
Annual Net Income, $ -30,780 K
60-Month Beta 1.12
% of Insider Shareholders 43.80%
% of Institutional Shareholders 7.03%
Float, K 43,675
% Float 56.20%

Growth:

1-Year Return -27.87%
3-Year Return -96.57%
5-Year Return -97.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 52.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/21/19
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GNMX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -898.31%
Return-on-Assets % -286.73%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar